What happened
Genesystem disclosed convertible bonds to raise US$4.27M, about 16.4% of its market value.
For context, this raise equals about 16.4% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$4.27M |
| vs. market value | 16.4% |
| Filed | 2026-09-30, Material event report (convertible bonds) |
| Source | DART rcept 20260930000411 → open original filing |
Source: DART. Information only, not investment advice.